C
Claus Højbjerg Gravholt
Researcher at Aarhus University Hospital
Publications - 295
Citations - 14915
Claus Højbjerg Gravholt is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Turner syndrome & Population. The author has an hindex of 58, co-authored 269 publications receiving 12630 citations. Previous affiliations of Claus Højbjerg Gravholt include Steno Diabetes Center & Aarhus University.
Papers
More filters
Journal ArticleDOI
Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study.
TL;DR: The prevalence of Klinefelter syndrome prenatally and postnatally in Denmark and the influence of maternal age were described and it was found that advanced maternal age had a significant impact on the prevalence.
Journal ArticleDOI
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Claus Højbjerg Gravholt,Niels Holmark Andersen,Gerard S. Conway,Olaf M. Dekkers,Mitchell E. Geffner,Karen O Klein,Angela E. Lin,Nelly Mauras,Charmian A. Quigley,Karen Rubin,David E. Sandberg,Theo C. J. Sas,Michael Silberbach,Viveca Söderström-Anttila,Kirstine Stochholm,Janielle A van Alfen-van derVelden,Joachim Woelfle,Philippe Backeljauw +17 more
TL;DR: An international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016, the present guidelines related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy.
Journal ArticleDOI
Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome
TL;DR: Patients with TS and especially the karyotypes 45,X and isoXq have a higher mortality compared with the background population, and there was a steady increase in prevalence, but incidence was unchanged.
Journal ArticleDOI
Morbidity in Turner syndrome.
TL;DR: The data suggest that patients with Turner syndrome are extraordinarily prone to abnormalities constituting the metabolic syndrome (e.g., hypertension, dyslipidaemia, NIDDM, obesity, hyperinsulinemia and hyperuricemia), which may help to explain the decreased life span found in patients withTurner syndrome.
Journal ArticleDOI
Recommendations for the diagnosis and management of Turner syndrome
Paul Saenger,K Albertsson Wikland,Gerard S. Conway,Marsha L. Davenport,Claus Højbjerg Gravholt,Raymond L. Hintz,Outi Hovatta,M. Hultcrantz,Kerstin Landin-Wilhelmsen,Alvin Lin,Barbara Lippe,A. M. Pasquino,Michael B. Ranke,Ron G. Rosenfeld,Michael Silberbach +14 more
TL;DR: An international multidisciplinary workshop was convened in March 2000, in Naples, Italy, in conjunction with the Fifth International Symposium on Turner Syndrome to update recommendations on the diagnosis of Turner syndrome.